Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (window အသစ် ဖွင့်နေပါတယ်)

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

ရင်းမြစ်‎: Ann Intern Med 2008;148(12):939-55.

Index လုပ်ထား‎: PubMed 18458272

https://www.ncbi.nlm.nih.gov/pubmed/18458272 (window အသစ် ဖွင့်နေပါတယ်)

Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. (window အသစ် ဖွင့်နေပါတယ်)

Moore RD, Charache S, Terrin ML, Barton FB, Ballas SK.

ရင်းမြစ်‎: Am J Hematol 2000;64(1):26-31.

Index လုပ်ထား‎: PubMed 10815784

https://www.ncbi.nlm.nih.gov/pubmed/10815784 (window အသစ် ဖွင့်နေပါတယ်)

Hydroxyurea for the treatment of sickle cell anemia. (window အသစ် ဖွင့်နေပါတယ်)

Platt OS.

ရင်းမြစ်‎: N Engl J Med 2008;358(13):1362-9.

Index လုပ်ထား‎: PubMed 18367739

DOI‎: 10.1056/NEJMct0708272

https://www.ncbi.nlm.nih.gov/pubmed/18367739 (window အသစ် ဖွင့်နေပါတယ်)

Clinical effectiveness of decitabine in severe sickle cell disease. (window အသစ် ဖွင့်နေပါတယ်)

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

ရင်းမြစ်‎: Br J Haematol 2008;141(1):126-9.

Index လုပ်ထား‎: PubMed 18324975

DOI‎: 10.1111/j.1365-2141.2008.07027.x

https://www.ncbi.nlm.nih.gov/pubmed/18324975 (window အသစ် ဖွင့်နေပါတယ်)

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (window အသစ် ဖွင့်နေပါတယ်)

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

ရင်းမြစ်‎: Blood 2010;115(12):2354-63.

Index လုပ်ထား‎: PubMed 19903897

DOI‎: 10.1182/blood-2009-05-221333

https://www.ncbi.nlm.nih.gov/pubmed/19903897 (window အသစ် ဖွင့်နေပါတယ်)

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (window အသစ် ဖွင့်နေပါတယ်)

Hirst C, Owusu-Ofori S.

ရင်းမြစ်‎: Cochrane Database Syst Rev 2012;(9):CD003427.

Index လုပ်ထား‎: PubMed 22972063

DOI‎: 10.1002/14651858.CD003427.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22972063 (window အသစ် ဖွင့်နေပါတယ်)

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. (window အသစ် ဖွင့်နေပါတယ်)

Howard J, Ataga KI, Brown RC, Achebe M, Nduba V, El-Beshlawy A, Hassab H, Agodoa I, Tonda M, Gray S, Lehrer-Graiwer J, Vichinsky E

ရင်းမြစ်‎: Lancet Haematol 2021;8(5):e323-33.

Index လုပ်ထား‎: PubMed 33838113

DOI‎: 10.1016/S2352-3026(21)00059-4

https://www.ncbi.nlm.nih.gov/pubmed/33838113 (window အသစ် ဖွင့်နေပါတယ်)

Sickle cell disease. (window အသစ် ဖွင့်နေပါတယ်)

Meremikwu MM, Okomo U.

ရင်းမြစ်‎: BMJ Clin Evid 2011;02:2402.

Index လုပ်ထား‎: PubMed 21718552

https://www.ncbi.nlm.nih.gov/pubmed/21718552 (window အသစ် ဖွင့်နေပါတယ်)

A phase 3 trial of l-glutamine in sickle cell disease. (window အသစ် ဖွင့်နေပါတယ်)

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP

ရင်းမြစ်‎: N Engl J Med 2018;379(3):226-35.

Index လုပ်ထား‎: PubMed 30021096

DOI‎: 10.1056/NEJMoa1715971

https://www.ncbi.nlm.nih.gov/pubmed/30021096 (window အသစ် ဖွင့်နေပါတယ်)

Malaria chemoprophylaxis in sickle cell disease. (window အသစ် ဖွင့်နေပါတယ်)

Oniyangi O, Omari AA.

ရင်းမြစ်‎: Cochrane Database Syst Rev 2006;(4):CD003489.

Index လုပ်ထား‎: PubMed 17054173

DOI‎: 10.1002/14651858.CD003489.pub2

https://www.ncbi.nlm.nih.gov/pubmed/17054173 (window အသစ် ဖွင့်နေပါတယ်)